COV2008
This study is investigating the safety and efficacy of the Johnson & Johnson Adv.26 booster vaccine in healthy adults who have previously received the Pfizer COVID-19 vaccine. This study is currently enrolling participants.
REGN COV-2069
/in Enrollment CompleteThis study is assessing antibodies for the prevention of SARS CoV-2 infection of asymptomatic healthy adults.
COV1001
/in Enrollment CompleteThis study is assessing two different dosages of an investigational COVID-19 vaccine in healthy adults. This trial completed enrollment in August 2020 and is ongoing.
Ascent – IPCAVD012/HVTN118
/in Enrollment CompleteThis study is evaluating different vaccine regimens using experimental HIV vaccines in healthy HIV-negative adults. The study finished enrollment in September 2017 and is ongoing.
Z002
/in Enrollment CompleteThis study assessed two different dosages of an investigational Zika Virus vaccine in healthy adults. The study closed enrollment in September 2018. Data analysis is underway.
T001
/in Enrollment CompleteThis study assessed different dosages of a monoclonal antibody in healthy HIV-negative and healthy HIV-positive adults. The study closed enrollment in October 2018.
T002
/in Enrollment CompleteThis study evaluated different dosages of a monoclonal antibody given in healthy HIV-negative and healthy HIV-positive adults. The study closed enrollment in October 2018.
T003
/in Enrollment CompleteThis study is assessing the use of an infusion of three antibodies as an alternative treatment for people living with HIV.
HTX1002
/in Enrollment CompleteThis study is assessing a therapeutic HIV vaccine as an alternative treatment for people living with HIV. This trial completed enrollment in January 2020 and is ongoing.
Center for Virology and Vaccine Research
3 Blackfan Circle
Boston, MA 02115 – USA
T 617.667.7000
F 617.735.4566
E CVVRcontact@bidmc.harvard.edu
CVVR Clinical Trials Unit
T 617.735.4610
E CVVRtrials@bidmc.harvard.edu